NM_001036.6:c.*839A>G

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1

The NM_001036.6(RYR3):​c.*839A>G variant causes a 3 prime UTR change. The variant allele was found at a frequency of 0.615 in 154,892 control chromosomes in the GnomAD database, including 31,527 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.61 ( 30745 hom., cov: 32)
Exomes 𝑓: 0.73 ( 782 hom. )

Consequence

RYR3
NM_001036.6 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 4.91

Publications

42 publications found
Variant links:
Genes affected
RYR3 (HGNC:10485): (ryanodine receptor 3) The protein encoded by this gene is a ryanodine receptor, which functions to release calcium from intracellular storage for use in many cellular processes. For example, the encoded protein is involved in skeletal muscle contraction by releasing calcium from the sarcoplasmic reticulum followed by depolarization of T-tubules. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2011]
AVEN (HGNC:13509): (apoptosis and caspase activation inhibitor) Involved in negative regulation of apoptotic process. Located in membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.29).
BP6
Variant 15-33866065-A-G is Benign according to our data. Variant chr15-33866065-A-G is described in ClinVar as Benign. ClinVar VariationId is 706987.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.739 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RYR3NM_001036.6 linkc.*839A>G 3_prime_UTR_variant Exon 104 of 104 ENST00000634891.2 NP_001027.3 Q15413-1
AVENNM_020371.3 linkc.*548T>C downstream_gene_variant ENST00000306730.8 NP_065104.1 Q9NQS1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RYR3ENST00000634891.2 linkc.*839A>G 3_prime_UTR_variant Exon 104 of 104 1 NM_001036.6 ENSP00000489262.1 Q15413-1
AVENENST00000306730.8 linkc.*548T>C downstream_gene_variant 1 NM_020371.3 ENSP00000306822.3 Q9NQS1

Frequencies

GnomAD3 genomes
AF:
0.613
AC:
93121
AN:
151898
Hom.:
30745
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.352
Gnomad AMI
AF:
0.764
Gnomad AMR
AF:
0.707
Gnomad ASJ
AF:
0.639
Gnomad EAS
AF:
0.451
Gnomad SAS
AF:
0.566
Gnomad FIN
AF:
0.725
Gnomad MID
AF:
0.573
Gnomad NFE
AF:
0.745
Gnomad OTH
AF:
0.631
GnomAD4 exome
AF:
0.726
AC:
2086
AN:
2874
Hom.:
782
Cov.:
0
AF XY:
0.723
AC XY:
1114
AN XY:
1540
show subpopulations
African (AFR)
AF:
0.389
AC:
7
AN:
18
American (AMR)
AF:
0.746
AC:
412
AN:
552
Ashkenazi Jewish (ASJ)
AF:
0.417
AC:
5
AN:
12
East Asian (EAS)
AF:
0.588
AC:
20
AN:
34
South Asian (SAS)
AF:
0.573
AC:
102
AN:
178
European-Finnish (FIN)
AF:
0.731
AC:
316
AN:
432
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.749
AC:
1156
AN:
1544
Other (OTH)
AF:
0.654
AC:
68
AN:
104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.524
Heterozygous variant carriers
0
27
55
82
110
137
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.613
AC:
93135
AN:
152018
Hom.:
30745
Cov.:
32
AF XY:
0.613
AC XY:
45542
AN XY:
74318
show subpopulations
African (AFR)
AF:
0.352
AC:
14574
AN:
41414
American (AMR)
AF:
0.708
AC:
10810
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.639
AC:
2220
AN:
3472
East Asian (EAS)
AF:
0.452
AC:
2334
AN:
5168
South Asian (SAS)
AF:
0.566
AC:
2731
AN:
4824
European-Finnish (FIN)
AF:
0.725
AC:
7669
AN:
10578
Middle Eastern (MID)
AF:
0.555
AC:
162
AN:
292
European-Non Finnish (NFE)
AF:
0.745
AC:
50621
AN:
67976
Other (OTH)
AF:
0.625
AC:
1317
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1659
3319
4978
6638
8297
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
758
1516
2274
3032
3790
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.696
Hom.:
152299
Bravo
AF:
0.600
Asia WGS
AF:
0.497
AC:
1729
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Epileptic encephalopathy Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.29
CADD
Benign
14
DANN
Benign
0.79
PhyloP100
4.9
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1044129; hg19: chr15-34158266; COSMIC: COSV60734207; COSMIC: COSV60734207; API